Cholera Market

By Treatment Type;

Medication and Vaccinations

By Product Type;

Suspension and Injectable

By Route of Administration;

Oral Dosage and Injectable Dosage

By End Users;

Hospitals, Homecare, Primary Care Provider, Specialty Clinics, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn994876184 Published Date: August, 2025 Updated Date: September, 2025

Cholera Market Overview

Cholera Market (USD Million)

Cholera Market was valued at USD 72.43 million in the year 2024. The size of this market is expected to increase to USD 83.20 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 2.0%.


Cholera Market

*Market size in USD million

CAGR 2.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)2.0 %
Market Size (2024)USD 72.43 Million
Market Size (2031)USD 83.20 Million
Market ConcentrationHigh
Report Pages327
72.43
2024
83.20
2031

Major Players

  • Valneva SE
  • Sanofi
  • Emergent BioSolutions Inc
  • EUBIOLOGICS CO., LTD
  • Astellas Pharma Inc
  • Johnson & Johnson
  • Celldex Therapeutics
  • GlaxoSmithKline plc
  • Merck & Co

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Cholera Market

Fragmented - Highly competitive market without dominant players


The Cholera Market is witnessing steady growth driven by increasing concerns about infectious outbreaks and the urgent need for preventive healthcare solutions. With reported cases rising by 25%, there is a notable shift toward stronger diagnostic tools and vaccine adoption. This expanding demand is shaping future innovations in cholera management.

Growing Emphasis on Vaccines and Preventive Care
The role of vaccination programs has grown substantially, with nearly 40% of health initiatives now prioritizing cholera immunization. Preventive care strategies and awareness drives are boosting population-level immunity, creating momentum in the global health space.

Technological Advancements in Diagnostics
Diagnostic technologies are evolving, with around 45% of hospitals and clinics integrating rapid test kits for immediate detection. Advanced digital healthcare systems are improving monitoring capabilities, ensuring effective outbreak response. This technological edge is strengthening the market presence.

Rising Focus on Therapeutics
On the treatment side, nearly 30% of medical research efforts are being channeled into innovative therapeutic solutions. Developments in oral rehydration therapy and antibiotic-based interventions are enhancing patient survival and reducing severe outcomes, consolidating the importance of effective drug pipelines.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment Type
    2. Market Snapshot, By Product Type
    3. Market Snapshot, By Route of Administration
    4. Market Snapshot, By End Users
    5. Market Snapshot, By Region
  4. Cholera Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising demand for cholera vaccines
        2. Focus on preventive healthcare
        3. Increased funding
      2. Restraints
        1. High costs
        2. Stringent regulations
        3. Limited access to healthcare
      3. Opportunities
        1. Focus on endemic regions
        2. Development of new delivery methods
        3. Increased public-private partnerships
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Cholera Market, By Treatment Type, 2021 - 2031 (USD Million)
      1. Medication
      2. Vaccinations
    2. Cholera Market, By Product Type, 2021 - 2031 (USD Million)
      1. Suspension
      2. Injectable
    3. Cholera Market, By Route of Administration, 2021 - 2031 (USD Million)
      1. Oral dosage
      2. Injectable dosage
    4. Cholera Market, By End Users, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Homecare
      3. Primary Care Provider
      4. Specialty Clinics
      5. Others
    5. Cholera Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Valneva SE
      2. Sanofi
      3. Emergent BioSolutions Inc
      4. EUBIOLOGICS CO., LTD
      5. Astellas Pharma Inc, Johnson & Johnson
      6. Celldex Therapeutics
      7. GlaxoSmithKline plc
      8. Merck & Co., Inc
  7. Analyst Views
  8. Future Outlook of the Market